From the broadcast script.
COLD OPEN
Over fourteen thousand peer-reviewed studies. On one single spice.
Anti-inflammatory. Anti-cancer. Neuroprotective. The evidence is not subtle.
The FDA has approved zero of those claims. Zero.
ACT ONE — THE COMPOUND
Curcumin. The active compound in turmeric. Indian and Chinese healers knew it five thousand years ago.
Modern science confirmed what they already knew. Curcumin modulates over one hundred molecular targets in the body.
It crosses the blood-brain barrier. It reduces amyloid plaque. The implications for Alzheimer research are enormous.
A compound that fights inflammation at the molecular level. Available at every grocery store for four dollars.
ACT TWO — THE SUPPRESSION
So why has the FDA never approved curcumin as a treatment? The answer is not complicated.
You cannot patent a plant. No patent means no exclusive market. No market means no profit incentive for clinical trials.
A single FDA-approved drug costs on average two point six billion dollars to bring to market. Nobody spends that on something they cannot own.
The system does not suppress turmeric because it does not work. It suppresses turmeric because it cannot be monetized.
ACT THREE — THE HACK
But there is something they really do not want you to know.
Curcumin has poor bioavailability. Your body cannot absorb it well. Unless you add one thing.
Black pepper. Piperine increases curcumin absorption by two thousand percent. Twenty times more.
Two ingredients. Available everywhere. Combined cost: five dollars. And the F.I.B. cannot do a thing about it.
CLOSING
Fourteen thousand studies. Five thousand years of use. Four dollars at the store. Zero FDA approvals.
The confidential dose was never confidential. It was just inconvenient for the wrong people.